ELF

Business Context and Reporting Period

Company: E.L.F. Beauty, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended December 31, 2024 (Fiscal Q3 2025)
Business Overview: A multi-brand beauty company offering inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare. Key brands include e.l.f. Cosmetics, e.l.f. SKIN, Naturium, Well People, and Keys Soulcare. The company distributes products through leading retailers (Target, Walmart, Ulta Beauty) and direct-to-consumer e-commerce channels.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 31% year-over-year (YoY) in Q3 and 40% for the nine-month period. Growth was driven by volume increases (81.2M in Q3) and higher average item prices/mix. Retailer channel sales grew 34% in Q3, while e-commerce grew 21%.
• Profitability Pressure: While gross margin expanded slightly (40 bps in Q3), operating income declined 19% YoY for the nine-month period ($113.7M vs $132.6M). Net income decreased 36% YoY in Q3 and 26% for the nine-month period.
• Expense Expansion: Selling, General, and Administrative (SG&A) expenses rose significantly, increasing 36% in Q3 and 61% for the nine-month period. Key drivers included:
  • Marketing and digital spend increases ($26.5M in Q3; $93.4M in 9M).
  • Compensation and benefits increases ($17.7M in Q3; $51.6M in 9M), partially due to a new retirement policy accelerating stock-based compensation vesting.
  • Increased operations, administrative, and retail fixturing costs.
• Cash Flow Shift: Operating cash flow turned negative for the nine months ended Dec 31, 2024 ($2.3M used), compared to $34.1M provided in the prior year. This was primarily due to a $178.1M increase in working capital, driven by higher accounts receivable ($65.1M), inventory ($23.7M), and prepaid expenses ($77.5M).
• Debt and Liquidity: Total debt remains elevated at $254.8M. The company utilized an incremental term loan and revolving credit facility to fund the Naturium acquisition. As of Dec 31, 2024, $10.5M remained available under the revolving credit facility.

Guidance, Outlook, and Risks

• Share Repurchase Program: On August 27, 2024, the Board authorized a new $500 million share repurchase program. No shares were repurchased under this new program in Q3 2024. The previous $25M program was exhausted in Q2 2024.
• Seasonality: The company notes that Q3 and Q4 are typically higher sales quarters due to holiday purchasing and shelf resets. Fluctuations in retailer order patterns can significantly impact quarterly results.
• Key Risks:
  • Supply Chain & Geopolitics: Significant exposure to China for manufacturing and sourcing. Risks include new tariffs (e.g., 10% tariff on Chinese goods announced Feb 1, 2025), port congestion, and Red Sea disruptions increasing freight costs.
  • Regulatory Compliance: Ongoing compliance with the Modernization of Cosmetics Regulation Act (MoCRA) and evolving data privacy laws (GDPR, CCPA).
  • Competition: Highly competitive market with pressure from new product introductions and pricing strategies by competitors.
  • Customer Concentration: Reliance on a limited number of major retailers for a large portion of net sales.

Investor Verification Checklist

• Working Capital Efficiency: Verify the sustainability of the $178M increase in working capital and the impact on future operating cash flows.
• SG&A Leverage: Monitor whether SG&A expenses as a percentage of sales (61% in Q3) stabilize as revenue growth continues.
• Tariff Impact: Assess the financial impact of the new 10% tariff on Chinese imports announced in February 2025 on future gross margins.
• Debt Covenants: Confirm continued compliance with leverage ratios under the Amended Credit Agreement, especially given the $500M repurchase authorization.
• Naturium Integration: Evaluate the performance of the Naturium acquisition (completed Oct 2023) and its contribution to the reported growth.